Pig islet xenotransplantation
- 1 October 2017
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Organ Transplantation
- Vol. 22 (5), 452-462
- https://doi.org/10.1097/mot.0000000000000455
Abstract
The current article reviews the rationale, sources and preparation of pig islets for xenotransplantation, and presents current progress in solving the problems associated with establishing pig islet transplant as a clinical treatment for type 1 diabetes. Islet transplantation is an effective treatment option for type 1 diabetes, but the available supply of human pancreases is insufficient to meet the need and demand for obtaining islets. Pig islets provide a readily available source for islet transplantation, with trials in non-human primates demonstrating their potential to reverse diabetes. The risk of zoonosis can be reduced by designated pathogen-free breeding of the donor pigs, but porcine endogenous retroviruses (PERVs) that are integrated into the genome of all pigs are especially difficult to eliminate. However, clinical trials have demonstrated an absence of PERV transmission with a significant reduction in the number of severe hypoglycemic episodes and up to 30% reduction in exogenous insulin doses. A number of methods such as production of various transgenic pigs to better xenotransplantation efficiency and the encapsulation of islets to isolate them from the host immune system are currently being tested to overcome the xenograft immune rejection. Furthermore, ongoing research is also shedding light on factors such as the age and breed of the donor pig to determine the optimal islet quantity and function.Keywords
This publication has 100 references indexed in Scilit:
- National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participantsThe Lancet, 2011
- Potential impact of the non‐human sialic acid N‐glycolylneuraminic acid on transplant rejection riskXenotransplantation, 2011
- Improved Method of Porcine Pancreas Procurement With Arterial Flush and Ductal Injection Enhances Islet Isolation OutcomeTransplantation Proceedings, 2010
- Synthesis of multilayered alginate microcapsules for the sustained release of fibroblast growth factor‐1Journal of Biomedical Materials Research Part A, 2010
- The potential of genetically-modified pig mesenchymal stromal cells in xenotransplantationXenotransplantation, 2010
- The perspectives for porcine-to-human xenograftsComparative Immunology, Microbiology and Infectious Diseases, 2009
- Dissecting the instant blood‐mediated inflammatory reaction in islet xenotransplantationXenotransplantation, 2008
- Functionally important glycosyltransferase gain and loss during catarrhine primate emergenceProceedings of the National Academy of Sciences, 2007
- Simultaneous expression by porcine aorta endothelial cells of glycosphingolipids bearing the major epitope for human xenoreactive antibodies (Gal?1?3Gal), blood group H determinant andN-glycolylneuraminic acidGlycoconjugate Journal, 1996
- Genetically engineered pigsThe Lancet, 1993